<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
	<channel>
		<title>OOIR Trends: Clinical Medicine (Medicine, Research &amp; Experimental)</title>
		<description>Aktuelle Paper-Trends im Bereich Clinical Medicine (Medicine, Research &amp; Experimental) von OOIR (mit Titel und Metadaten von Crossref)</description>
		<link>https://ooir.org</link>
		<language>en-us</language>
		<pubDate>Thu, 02 Oct 2025 00:59:30 GMT</pubDate>
		<lastBuildDate>Thu, 02 Oct 2025 00:59:30 GMT</lastBuildDate>
		<item>
			<title>1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea</title>
			<link>https://doi.org/10.1186/s40364-025-00831-w</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, Research &amp; Experimental
Score: 1941
Autoren: Hong Jin Kim, Min-Ho Kim, Myeong Geun Choi, Eun Mi Chun
Journal: Biomarker Research
Veröffentlicht: 2025-09-26
Abstract: Abstract
          The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206–1.514), gastric (HR, 1.335; 95% CI, 1.130–1.576), colorectal (HR, 1.283; 95% CI, 1.122–1.468), lung (HR, 1.533; 95% CI, 1.254–1.874), breast (HR, 1.197; 95% CI, 1.069–1.340), and prostate (HR, 1.687; 95% CI, 1.348–2.111) cancers significantly increased at 1 year post-vaccination. In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination.
DOI: 10.1186/s40364-025-00831-w
ISSN: 2050-7771
Tag der Erhebung (OOIR): 2025-10-02</description>
			<guid isPermaLink="false">ooir-trend-10.1186/s40364-025-00831-w-2025-10-02-1</guid>
			<pubDate>Fri, 26 Sep 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Heat-related mortality in Europe during 2024 and health emergency forecasting to reduce preventable deaths</title>
			<link>https://doi.org/10.1038/s41591-025-03954-7</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, Research &amp; Experimental
Score: 906
Autoren: Tomáš Janoš, Marcos Quijal-Zamorano, Natalia Shartova, Elisa Gallo, Raúl Fernando Méndez Turrubiates, Nadia Denisse Beltrán Barrón, Fabien Peyrusse, Joan Ballester
Journal: Nature Medicine
Veröffentlicht: 2025-09-22
DOI: 10.1038/s41591-025-03954-7
ISSN: 1078-8956
Tag der Erhebung (OOIR): 2025-10-02</description>
			<guid isPermaLink="false">ooir-trend-10.1038/s41591-025-03954-7-2025-10-02-2</guid>
			<pubDate>Mon, 22 Sep 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation</title>
			<link>https://doi.org/10.1126/scitranslmed.adt7214</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, Research &amp; Experimental
Score: 553
Autoren: Ziyuan He, Marla C. Glass, Pravina Venkatesan, Marie L. Feser, Leander Lazaro, Lauren Y. Okada, Nhung T. T. Tran, Yudong D. He, Samir Rachid Zaim, Christy E. Bennett, Padmapriyadarshini Ravisankar, Elisabeth M. Dornisch, Alexandra C. Ferrannini, Najeeb A. Arishi, Ashley G. Asamoah, Saman Barzideh, Lynne A. Becker, Elizabeth A. Bemis, Jane H. Buckner, Christopher E. Collora, Megan A. L. Criley, M. Kristen Demoruelle, Chelsie L. Fleischer, Jessica Garber, Palak C. Genge, Qiuyu Gong, Lucas T. Graybuck, Claire E. Gustafson, Brian C. Hattel, Veronica Hernandez, Alexander T. Heubeck, Erin K. Kawelo, Upaasana Krishnan, Emma L. Kuan, Kristine A. Kuhn, Christian M. LaFrance, Kevin J. Lee, Ruoxin Li, Cara Lord, Regina R. Mettey, Laura Moss, Blessing Musgrove, Katherine HY Nguyen, Andrea Ochoa, Vaishnavi Parthasarathy, Mark-Phillip Pebworth, Chong Pedrick, Tao Peng, Cole G. Phalen, Julian Reading, Charles R. Roll, Jennifer A. Seifert, Marguerite D. Siedschlag, Cate Speake, Christopher C. Striebich, Tyanna J. Stuckey, Elliott G. Swanson, Hideto Takada, Tylor Thai, Zachary J. Thomson, Nguyen Trieu, Vlad Tsaltskan, Wei Wang, Morgan D. A. Weiss, Amy Westermann, Fan Zhang, David L. Boyle, Ananda W. Goldrath, Thomas F. Bumol, Xiao-jun Li, V. Michael Holers, Peter J. Skene, Adam K. Savage, Gary S. Firestein, Kevin D. Deane, Troy R. Torgerson, Mark A. Gillespie
Journal: Science Translational Medicine
Veröffentlicht: 2025-09-24
Abstract: 
            Rheumatoid arthritis (RA) is preceded by an at-risk stage of disease that can be marked by the presence of anticitrullinated protein antibodies (ACPAs) but the absence of clinically apparent synovitis (clinical RA). Preemptive intervention in at-risk individuals could prevent or delay future tissue damage; however, the immunobiology of this stage is unclear. Using integrative multiomics, we longitudinally profiled at-risk individuals, where one-third of participants developed clinical RA on study. We found evidence of systemic inflammation and signatures of activation in naïve T and B cells of at-risk individuals. During progression to clinical RA, proinflammatory skewing of atypical B cells and expansion of memory CD4 T cells with signatures of activation and B cell help were present without elevations in circulating ACPA titers. Epigenetic changes in naïve CD4 T cells suggested a predisposition to differentiate into effector cells capable of B cell help. These findings characterize pathogenesis of the ACPA
            +
            at-risk stage and support the concept that the disease begins much earlier than clinical RA. Additionally, an extensive immune resource of the at-risk stage and progression to clinical RA with interactive tools was developed to enable further investigation.
          
DOI: 10.1126/scitranslmed.adt7214
ISSN: 1946-6234
Tag der Erhebung (OOIR): 2025-10-02</description>
			<guid isPermaLink="false">ooir-trend-10.1126/scitranslmed.adt7214-2025-10-02-3</guid>
			<pubDate>Wed, 24 Sep 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial</title>
			<link>https://doi.org/10.1038/s41591-025-03877-3</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, Research &amp; Experimental
Score: 382
Autoren: Angela DeMichele, Amy S. Clark, Emily Shea, Lauren J. Bayne, Christopher J. Sterner, Killian Rohn, Samantha Dwyer, Tien-chi Pan, Isoris Nivar, Yan Chen, Paul Wileyto, Lindsay R. Berry, Shannon Deluca, Jessica Savage, Igor Makhlin, Dhruv K. Pant, Heather Martin, Adetutu Egunsola, Nathan Mears, Brooke L. Goodspeed, Elizabeth M. Chislock, Jewell Graves, Jianping Wang, Natalie Shih, George K. Belka, Don Berry, Anupma Nayak, Michael Feldman, Lewis A. Chodosh
Journal: Nature Medicine
Veröffentlicht: 2025-09-02
DOI: 10.1038/s41591-025-03877-3
ISSN: 1078-8956
Tag der Erhebung (OOIR): 2025-10-02</description>
			<guid isPermaLink="false">ooir-trend-10.1038/s41591-025-03877-3-2025-10-02-4</guid>
			<pubDate>Tue, 02 Sep 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity</title>
			<link>https://doi.org/10.1038/s41591-025-03893-3</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, Research &amp; Experimental
Score: 374
Autoren: Hamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek, Nicholas J. Casacchia, Abdullah Al Jabri, James Bena, Xiaoxi Feng, Rickesha Wilson, Ricard Corcelles, W. Scott Butsch, Rishi P. Singh, Nikhil Das, Hejin Jeong, Amgad Mentias, W. H. Wilson Tang, Bartolome Burguera, Raul J. Rosenthal, Steven E. Nissen, Michael B. Rothberg, Ali Aminian
Journal: Nature Medicine
Veröffentlicht: 2025-09-16
DOI: 10.1038/s41591-025-03893-3
ISSN: 1078-8956
Tag der Erhebung (OOIR): 2025-10-02</description>
			<guid isPermaLink="false">ooir-trend-10.1038/s41591-025-03893-3-2025-10-02-5</guid>
			<pubDate>Tue, 16 Sep 2025 00:00:00 GMT</pubDate>
		</item>
	</channel>
</rss>